Notwithstanding, as L1CAM overexpression was shown to be particularly related with atypical endometriotic lesions [5], it is possible that anti-L1 mAb treatment might be most effective only for patients with atypical endometriosis. The gene discussed is L1CAM; the disease is endometriosis.